Здравни новини

Human medicines European public assessment report (EPAR): Yuviwel, Navepegritide, Status: Opinion

Human medicines European public assessment report (EPAR): Kizfizo, temozolomide, Status: Opinion

Human medicines European public assessment report (EPAR): Foundayo, Orforglipron, Status: Opinion

Human medicines European public assessment report (EPAR): Neuzafy, filgrastim, Status: Opinion

Human medicines European public assessment report (EPAR): Fovlussea, ranibizumab, Ophthalmologicals, Status: Opinion

A three-day training workshop organised by ECDC and WHO/Europe and hosted by the Slovenian National Institute of Public Health (NIPH) brought together participants from the EU and a number of

...

With the EU experiencing its most intense West Nile virus season to date and detections of the virus in new areas further north in Europe, ECDC calls for sustained prevention, surveillance and

...

Since May 2026, an Ebola virus disease outbreak caused by Bundibugyo virus has been ongoing in the Democratic Republic of the Congo (DRC).

Following the reported death of a laboratory worker in Irkutsk, Russia, from pneumonia that is suspected to be pneumonic plague, ECDC is closely monitoring the situation. 

Every month ECDC provides detailed epidemiological overview of the worldwide transmission of chikungunya virus disease in its weekly threat report (Communicable Diseases Threat Report).